Ferrati, Silvia
Wu, Tian
Fuentes, Omar
Brunaugh, Ashlee D.
Kanapuram, Sekhar R.
Smyth, Hugh D. C.
Article History
Received: 21 December 2017
Accepted: 13 February 2018
First Online: 27 February 2018
Compliance with Ethical Standards
: The terms of this arrangement have been reviewed and approved by the University of Texas at Austin in accordance with its policy on objectivity in research.
: The author (HDCS) of this paper consults for and has equity ownership in Respira Therapeutics and Nob Hill Therapeutics on inhaled product development. The other authors declare that they have no conflict of interest.